Literature DB >> 15077653

The consumer's perspective and the professional literature: what do persons with spinal cord injury want?

Irene M Estores1.   

Abstract

Different motives and purposes drive research. New knowledge advances any discipline, and use of the information obtained from careful scientific study as the basis for clinical practice promotes patient care. It is important to consider the preferences of persons with spinal cord injury (SCI) and use this as the framework in formulating research questions and clinical applications of discoveries made in the laboratory. A literature review of articles related to the interests and concerns of persons with SCI was conducted through the National Library of Medicine resource. Patient interest in finding a "cure" for SCI was not directly ascertained by any of the studies reviewed. Mobility remains the area of greatest interest, and decreased mobility has been rated as the most difficult consequence to deal with after the injury. This review indicates a congruence of the interests of both patients and researchers. However, the methodology most often used to ascertain the preferences of persons with SCI may need to be supplemented with different approaches. In addition, these preferences and the factors that influence them should be longitudinally assessed.

Entities:  

Mesh:

Year:  2003        PMID: 15077653     DOI: 10.1682/jrrd.2003.08.0093

Source DB:  PubMed          Journal:  J Rehabil Res Dev        ISSN: 0748-7711


  23 in total

Review 1.  A systematic review of the effects of pharmacological agents on walking function in people with spinal cord injury.

Authors:  Antoinette Domingo; Abdulaziz A Al-Yahya; Yousif Asiri; Janice J Eng; Tania Lam
Journal:  J Neurotrauma       Date:  2012-02-29       Impact factor: 5.269

Review 2.  The health and life priorities of individuals with spinal cord injury: a systematic review.

Authors:  Lisa A Simpson; Janice J Eng; Jane T C Hsieh; Dalton L Wolfe
Journal:  J Neurotrauma       Date:  2012-04-18       Impact factor: 5.269

3.  Spinal Cord Injury Rehabilitation Evidence: Methods of the SCIRE Systematic Review.

Authors:  Janice J Eng; Robert Teasell; William C Miller; Dalton L Wolfe; Andrea F Townson; Jo-Anne Aubut; Caroline Abramson; Jane T Hsieh; Sandra Connolly; Kristin Konnyu
Journal:  Top Spinal Cord Inj Rehabil       Date:  2007

4.  Stem cell clinical trials for spinal cord injury: readiness, reluctance, redefinition.

Authors:  J Illes; J C Reimer; B K Kwon
Journal:  Stem Cell Rev Rep       Date:  2011-11       Impact factor: 5.739

5.  Assessing the ability of the Sacral Autonomic Standards to document bladder and bowel function based upon the Asia Impairment Scale.

Authors:  Marca Alexander; Conley Carr; Jagger Alexander; Yuying Chen; Amie McLain
Journal:  Spinal Cord Ser Cases       Date:  2019-10-18

6.  In delicate balance: stem cells and spinal cord injury advocacy.

Authors:  Sara Parke; Judy Illes
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

7.  Auricular acupuncture for spinal cord injury related neuropathic pain: a pilot controlled clinical trial.

Authors:  Irene Estores; Kevin Chen; Brian Jackson; Lixing Lao; Peter H Gorman
Journal:  J Spinal Cord Med       Date:  2016-02-15       Impact factor: 1.985

8.  Association between seeking oral health information online and knowledge in adults with spinal cord injury: a pilot study.

Authors:  Hon K Yuen; Andres Azuero; Steven London
Journal:  J Spinal Cord Med       Date:  2011       Impact factor: 1.985

9.  A toll-like receptor 9 antagonist improves bladder function and white matter sparing in spinal cord injury.

Authors:  Brian T David; Sujitha Sampath; Wei Dong; Adee Heiman; Courtney E Rella; Stella Elkabes; Robert F Heary
Journal:  J Neurotrauma       Date:  2014-08-25       Impact factor: 5.269

10.  Electrical stimulation of embryonic neurons for 1 hour improves axon regeneration and the number of reinnervated muscles that function.

Authors:  Yang Liu; Robert M Grumbles; Christine K Thomas
Journal:  J Neuropathol Exp Neurol       Date:  2013-07       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.